Private Capital Advisors, Inc. Moderna, Inc. Transaction History

Private Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$118.5 - $160.53 $201,450 - $272,901	1,700 New	1,700 $207,000
Q1 2021 May 03, 2021	SELL	$109.18 - $185.98 $314,984 - $536,552	-2,885 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$65.74 - $169.86 $189,659 - $490,046	2,885 New	2,885 $301,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Private Capital Advisors, Inc. with notifications on news.